Germany may be the largest and fastest-growing medical cannabis market in Europe, but signs are emerging from medical and regulatory circles that should serve as a warning to marijuana companies planning to commercialize medicines without conclusive clinical trials. In fact, businesses based on science and efficacy may see a competitive advantage in Germany in the
Germany’s medical cannabis market prioritizes efficacy over unfettered access is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
[Read More ...]
Originally posted on Germany’s medical cannabis market prioritizes efficacy over unfettered access via George Scorsis Medical Marijuana News
No comments:
Post a Comment